EUVIMEDEUVIMED entdecken
Open Access

PIK3R1 as a Gastric Cancer Biomarker Linked to CD73+ Treg-Mediated Immunosuppression

Bu Zou, Yi-En Xu, Hui-Chan He, Zu-Lu Ye, Da-Lei Zhou, Cai-Yun He, Chan Huang

Oncology Research · 2026 · 34 (2) · 1-10

DOI: 10.32604/or.2025.069453 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Bu Zou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center f…. Hauptthemen laut MEDLINE: Stomach Neoplasms, T-Lymphocytes, Regulatory, Biomarkers, Tumor, Class Ia Phosphatidylinositol 3-Kinase. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Gastric cancer (GC) remains a major global health concern, and Phosphoinositide-3-Kinase Regulatory Subunit 1 (PIK3R1), a regulatory subunit of the PI3K signaling pathway, may play a critical yet underexplored role in GC progression. This study aimed to investigate the prognostic significance of PIK3R1 in GC and its association with the tumor immune microenvironment.

Methods

PIK3R1 expression and its clinical relevance were analyzed using datasets from GC patients who underwent gastrectomy, including cohorts from The Cancer Genome Atlas (TCGA) and the Sun Yat-sen University Cancer Center (SYSUCC). Prognostic models integrating PIK3R1 expression with clinical parameters were constructed for both cohorts. The immune microenvironment associated with PIK3R1 expression was assessed through immunohistochemistry and single-cell RNA sequencing. In vitro assays were conducted to evaluate the effects of PIK3R1 on GC cell proliferation and migration.

Results

PIK3R1 was significantly overexpressed in GC tissues and was closely associated with aggressive tumor characteristics and poor clinical outcomes. A nomogram combining PIK3R1 expression with clinicopathological features effectively predicted patient prognosis. Knockdown of PIK3R1 in GC cells reduced proliferation and migration in vitro. Immunological profiling revealed that high PIK3R1 expression correlated with increased infiltration of forkhead box protein P3 (Foxp3+) and cluster of differentiation 73 (CD73+) T cells. Patients with low PIK3R1 expression and low CD73+ T cell infiltration had significantly better survival.

Conclusions

PIK3R1 overexpression is linked to poor prognosis in GC and influences the extent of immune cell infiltration within the tumor microenvironment. A novel prognostic model integrating PIK3R1 and CD73 expression with clinical parameters was established to stratify GC patients into distinct risk groups, offering potential value for personalized therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsT-Lymphocytes, RegulatoryBiomarkers, TumorClass Ia Phosphatidylinositol 3-Kinase5'-NucleotidaseHumansFemalePrognosisTumor MicroenvironmentMaleCell ProliferationMiddle AgedGene Expression Regulation, NeoplasticCell Line, Tumor

Stichwörter der Autor:innen

Cluster of differentiation 73gastric cancerimmune microenvironmentnomogramphosphoinositide-3-kinase regulatory subunit 1

Substanzen

PIK3R1 protein, humanBiomarkers, TumorClass Ia Phosphatidylinositol 3-Kinase5'-Nucleotidase

Autor:innen und Institutionen

  • Department of Head and Neck, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Department of Molecular Diagnostics, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Department of Blood Transfusion, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Department of Pathology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.

Zitieren

APA

Zou, B., Xu, Y. E., He, H. C., Ye, Z. L., Zhou, D. L., He, C. Y., & Huang, C. (2026). PIK3R1 as a Gastric Cancer Biomarker Linked to CD73+ Treg-Mediated Immunosuppression. Oncology Research, 34(2), 1-10. https://doi.org/10.32604/or.2025.069453

Vancouver

Zou B, Xu YE, He HC, Ye ZL, Zhou DL, He CY, et al. PIK3R1 as a Gastric Cancer Biomarker Linked to CD73+ Treg-Mediated Immunosuppression. Oncology Research. 2026;34(2):1-10. doi:10.32604/or.2025.069453

BibTeX
@article{Zou2026,
  author = {Zou, Bu and Xu, Yi-En and He, Hui-Chan and Ye, Zu-Lu and Zhou, Da-Lei and He, Cai-Yun and Huang, Chan},
  title = {PIK3R1 as a Gastric Cancer Biomarker Linked to CD73+ Treg-Mediated Immunosuppression},
  journal = {Oncology Research},
  year = {2026},
  volume = {34},
  number = {2},
  pages = {1--10},
  doi = {10.32604/or.2025.069453}
}
Kostenlos starten →